EMA Gives Oncopeptides’ Multiple Myeloma Drug The Thumbs Up; Keeps US FDA In Loop

Company’s Request For EU Conditional Approval Flipped To Full Marketing Authorization

 
• By Vibha Sharma
  
Woman writes in a notebook her observations on work, thoughts and ideas for improving business strategies.
FDA Was A Silent Observer At Most EMA Meetings For Evaluating Melphalan Flufenamide • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews